Zobrazeno 1 - 10
of 1 063
pro vyhledávání: '"Driouch, K"'
Autor:
Sablin MP; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Gestraud P; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Jonas SF; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Lamy C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., Lacroix-Triki M; Department of Pathology, Gustave Roussy, Villejuif, France., Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Filleron T; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France., Lacroix L; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Genomic Platform and Biobank, CNRS UMS3655-INSERM US23, AMMICA, Gustave Roussy, Villejuif, France., Tran-Dien A; Bioinformatics Platform, Gustave Roussy, Villejuif, France., Jézéquel P; Omics Data Science Unit, Institut de Cancérologie de l'Ouest (ICO), Angers-Nantes, France., Mauduit M; Precision Medicine Group, UNICANCER, Paris, France., Barros Monteiro J; R&D Unicancer, Paris, France., Jimenez M; Precision Medicine Group, UNICANCER, Paris, France., Michiels S; Service de Biostatistique et d'Épidémiologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Oncostat U1018, Inserm, Université Paris-Saclay, Équipe Labellisée Ligue Contre le Cancer, Villejuif, France., Attignon V; Cancer Genomic Platform, Centre Léon Bérard, Lyon, France., Soubeyran I; Department of Biopathology, Institut Bergonié, Bordeaux, France., Driouch K; Department of Genetics, Institut Curie, Paris University, Paris, France., Servant N; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France.; Bioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, Paris, France., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris, France., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Bièche I; Department of Genetics, Institut Curie, Paris University, Paris, France. ivan.bieche@curie.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Oct; Vol. 131 (6), pp. 1060-1067. Date of Electronic Publication: 2024 Aug 02.
Autor:
Taouis K; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Vacher S; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Guirouilh-Barbat J; Laboratoire Recombinaison-Réparation et Cancer UMR8200 Stabilité Génétique et Oncogenèse Institut Gustave Roussy, PR2, pièce 426114 Rue Edouard Vaillant, 94805, Villejuif, France., Camonis J; INSERM U528, Institut Curie, 26 rue d'Ulm, Paris, France., Formstecher E; Hybrigenics Services, 1 rue Pierre Fontaine, 91000, Evry, France., Popova T; Centre De Recherche, Institut Curie, Paris, F-75248, France.; INSERM U830, Paris, F-75248, France., Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, University Paris, Paris, France.; Department of Medical Oncology, Institut Curie, Paris, France.; University Paris, Paris, France., Petitalot A; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France., Lidereau R; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France., Caputo SM; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Zinn-Justin S; Institute for Integrative Biology of the Cell, CEA, CNRS, Université Paris-Sud, Gif-sur-Yvette, France., Bièche I; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U1016, Université Paris Descartes, 4 avenue de l'observatoire, Paris, France., Driouch K; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Lallemand F; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France. francois.lallemand@curie.fr.; Paris Sciences Lettres Research University, Paris, France. francois.lallemand@curie.fr.
Publikováno v:
Cancer gene therapy [Cancer Gene Ther] 2023 Aug; Vol. 30 (8), pp. 1144-1155. Date of Electronic Publication: 2023 May 29.
Autor:
El-Botty R; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Morriset L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Montaudon E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Tariq Z; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Schnitzler A; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Bacci M; Dept. of Experimental and Clinical Biomedical Sciences, Viale Morgagni, 50 - 50134, Florence, Italy., Lorito N; Dept. of Experimental and Clinical Biomedical Sciences, Viale Morgagni, 50 - 50134, Florence, Italy., Sourd L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Huguet L; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Dahmani A; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Painsec P; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Derrien H; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Vacher S; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Masliah-Planchon J; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Raynal V; ICGex - NGS platform, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Baulande S; ICGex - NGS platform, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Larcher T; INRA, APEX-PAnTher, Oniris, 44322, Rue de la Géraudière, Nantes, France., Vincent-Salomon A; Department of Pathology, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Dutertre G; Department of Surgery, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Cottu P; Department of Medical Oncology, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Gentric G; 'Stress and Cancer' Laboratory, Institut Curie - Inserm U830, PSL University, 26 rue d'Ulm, 75005, Paris, France., Mechta-Grigoriou F; 'Stress and Cancer' Laboratory, Institut Curie - Inserm U830, PSL University, 26 rue d'Ulm, 75005, Paris, France., Hutton S; Metabolon Inc., 617 Davis Drive, Suite 100, Morrisville, NC, 27560, USA., Driouch K; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France., Bièche I; Department of Genetics, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France.; Paris City University, Inserm U1016, Faculty of Pharmaceutical and Biological Sciences, 75005, Paris, France., Morandi A; Dept. of Experimental and Clinical Biomedical Sciences, Viale Morgagni, 50 - 50134, Florence, Italy., Marangoni E; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University, 26 rue d'Ulm, 75005, Paris, France. elisabetta.marangoni@curie.fr.
Publikováno v:
Nature communications [Nat Commun] 2023 Jul 14; Vol. 14 (1), pp. 4221. Date of Electronic Publication: 2023 Jul 14.
Autor:
Passeri T; Departments of1Genetics and.; Departments of2Neurosurgery.; 3Department of Translational Research, Laboratory of Preclinical Investigation, Institut Curie, Paris-Saclay University, Paris., Gutman T; 4Inserm U900, Institut Curie, Paris., Hamza A; Departments of1Genetics and., Adle-Biassette H; 5Pathology, and., Girard E; 4Inserm U900, Institut Curie, Paris., Beaurepere R; Departments of1Genetics and., Tariq Z; Departments of1Genetics and., Mariani O; 6Tumor Biology, Institut Curie, Paris., Dahmani A; 3Department of Translational Research, Laboratory of Preclinical Investigation, Institut Curie, Paris-Saclay University, Paris., Bourneix C; Departments of1Genetics and., Abbritti R; Departments of2Neurosurgery., Driouch K; Departments of1Genetics and., Bohec M; 7ICGex NGS Platform, Institut Curie, Paris., Servant N; 4Inserm U900, Institut Curie, Paris., Baulande S; 7ICGex NGS Platform, Institut Curie, Paris., Decaudin D; 3Department of Translational Research, Laboratory of Preclinical Investigation, Institut Curie, Paris-Saclay University, Paris., Guichard JP; 8Radiology, Lariboisière Hospital, Assistance Publique des Hôpitaux de Paris, University of Paris, Paris., Calugaru V; 9Department of Radiotherapy, Proton Therapy Center, Institut Curie, Paris-Saclay University, Orsay., Feuvret L; 10Department of Radiotherapy, Pitié-Salpêtrière Hospital, Assistance Publique des Hôpitaux de Paris, Paris., Guinebretière JM; 11Department of Pathology, Institut Curie, Paris-Saclay University, Paris; and., Champion L; 12Department of Nuclear Medicine, Institut Curie, Paris-Saclay University, Saint-Cloud, France., Bièche I; Departments of1Genetics and., Froelich S; Departments of2Neurosurgery., Mammar H; 9Department of Radiotherapy, Proton Therapy Center, Institut Curie, Paris-Saclay University, Orsay., Masliah-Planchon J; Departments of1Genetics and.
Publikováno v:
Journal of neurosurgery [J Neurosurg] 2023 Apr 07; Vol. 139 (5), pp. 1270-1280. Date of Electronic Publication: 2023 Apr 07 (Print Publication: 2023).
Autor:
Hamy AS; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France.; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Abécassis J; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INRIA, Université Paris-Saclay, CEA, Palaiseau, France., Driouch K; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Darrigues L; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Vandenbogaert M; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France., Laurent C; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Zaccarini F; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Sadacca B; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; INSERM U830, Institut Curie, PSL University, Paris, France., Delomenie M; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Laas E; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Mariani O; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France., Lam T; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France.; Department of Gynecology and Obstetrics, Geneva University Hospitals, Geneva, Switzerland., Grandal B; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France., Laé M; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France.; Department of Pathology, Centre Henri Becquerel, INSERM U1245, UNIROUEN, University of Normandie, Rouen, France., Bieche I; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France.; INSERM U1016, Faculty of Pharmaceutical and Biological Sciences, Université de Paris Cité, Paris, France., Vacher S; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Pierga JY; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Brain E; Department of Medical Oncology, Institut Curie, Université Paris Cité, Paris, France., Vallot C; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; CNRS UMR3244, Institut Curie, PSL University, Paris, France., Hotton J; Department of Surgical Oncology, Institut Godinot, Reims, France., Richer W; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France.; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France., Rocha D; Translational Immunotherapy Team, INSERM U932, Institut Curie, PSL University, Paris, France., Tariq Z; Pharmacogenomics Unit, Department of Genetics, PSL University, Institut Curie, Paris, France., Becette V; Biological Resource Center, Department of Pathology, Department of Diagnostic and Theranostic Medicine, Institut Curie, PSL University, Paris, France., Meseure D; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Lesage L; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Vincent-Salomon A; Department of Diagnostic and Theranostic Medicine, Institut Curie, University Paris-Sciences et Lettres, Paris, France., Filmann N; German Breast Group, Neu-Isenburg, Germany., Furlanetto J; German Breast Group, Neu-Isenburg, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology/Bethanien, Frankfurt am Main, Germany., Dumas E; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France., Waterfall JJ; Translational Research Department, Institut Curie Research Center, PSL University, Paris, France. joshua.waterfall@curie.fr.; INSERM U830, Institut Curie, PSL University, Paris, France. joshua.waterfall@curie.fr., Reyal F; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, Paris, INSERM, U932 Immunity and Cancer, Institut Curie, Université de Paris, Paris, France. fabien.reyal@curie.fr.; Department of Breast, Gynecological and Reconstructive Surgery, Institut Curie, Université de Paris Cité, Paris, France. fabien.reyal@curie.fr.
Publikováno v:
Nature medicine [Nat Med] 2023 Mar; Vol. 29 (3), pp. 646-655. Date of Electronic Publication: 2023 Mar 06.
Autor:
Bonin F; Genetics Department, Institut Curie, Paris, 75005, France., Chiche A; Cell Biology and Cancer Department/Unit 144, Institut Curie/Centre National de Recherche Scientifique, Paris, 75005, France.; Department of Developmental & Stem Cell Biology/ Unit 3738, Institut Pasteur/Centre National de Recherche Scientifique, Paris, 75015, France., Tariq Z; Genetics Department, Institut Curie, Paris, 75005, France., Azorin P; Genetics Department, Institut Curie, Paris, 75005, France., Nola S; Genetics Department, Institut Curie, Paris, 75005, France.; Membrane Traffic in Health And Brain Disease /Unit 1266, Institute of Psychiatry and Neuroscience of Paris/Institut National de la Santé et de la Recherche Médicale, Université de Paris, Paris, 75014, France., Lidereau R; Genetics Department, Institut Curie, Paris, 75005, France., Driouch K; Genetics Department, Institut Curie, Paris, 75005, France.
Publikováno v:
Cancer communications (London, England) [Cancer Commun (Lond)] 2022 Oct; Vol. 42 (10), pp. 1036-1040. Date of Electronic Publication: 2022 Jul 26.
Autor:
Bouteille, N.1,2, Driouch, K.1,2, Hage, P. El1,2, Sin, S.1,2, Formstecher, E.3, Camonis, J.4, Lidereau, R.1,2, Lallemand, F.1,2 f.lallemand@stcloud-huguenin.org
Publikováno v:
Oncogene. 7/16/2009, Vol. 28 Issue 28, p2569-2580. 12p. 1 Color Photograph, 7 Graphs.
Autor:
Azorin P; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Bonin F; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Tariq Z; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Petitalot A; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Coussy F; Department of Medical Oncology, Institut Curie, Paris, France., Marangoni E; Translational Research, Institut Curie, PSL Research University, Paris, France., Becette V; Pathology Department, Institut Curie, Paris, France., Denoux Y; Pathology Department, Foch Hospital, Suresnes, France., Vincent-Salomon A; Pathology Department, Institut Curie, Paris, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France., Larbi Cherif L; Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France., Klijanienko J; Pathology Department, Institut Curie, Paris, France., Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, Paris & Saint Cloud, France., Bièche I; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Lidereau R; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France., Driouch K; Pharmacogenomics Unit, Genetics Department, Institut Curie, Paris, France.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2022 Apr; Vol. 12 (4), pp. e813.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Santana Dos Santos E; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France. elizabeth.santanadossantos@gmail.com.; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France. elizabeth.santanadossantos@gmail.com.; Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.; Centro de Oncologia Hospital Sírio Libanês-São Paulo, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Carraro DM; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil., Briaux A; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Southey M; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France.; Department of Pathology, The University of Melbourne, 3010, Victoria, Australia., Torrezan G; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil., Petitalot A; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Leman R; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France., Lafitte P; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Meseure D; Department of Pathology, Institut Curie, 26 rue d'Ulm, Paris, France., Driouch K; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Side L; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Brewer C; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK., Beck S; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Melville A; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Callaway A; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK., Revillion F; Laboratory of Human Molecular Oncology - Centre Oscar Lambret, Lille Cedex, France., Folgueira MAAK; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Thorne H; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Vincent-Salomon A; Department of Pathology, Institut Curie, 26 rue d'Ulm, Paris, France., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Inserm U830, University Paris Descartes, Paris, France., Bieche I; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Faculty of Pharmaceutical and Biological Sciences, University of Paris, F-75006, Paris, France., Caputo SM; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France. etienne.rouleau@gustaveroussy.fr.
Publikováno v:
NPJ breast cancer [NPJ Breast Cancer] 2022 Jan 17; Vol. 8 (1), pp. 9. Date of Electronic Publication: 2022 Jan 17.